Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xueli Ding
Observed name:
X Ding
Institution:
Affiliated Hospital of Qingdao University
Observed institution:
Affiliated Hospital of Qingdao University
ORCID:
0000-0003-4021-2246
Observed ORCID:
0000-0003-4021-2246
OpenAlex ID:
A5123523270
Influence of metabolic syndrome on disease characteristics and activity in inflammatory bowel disease: A retrospective cohort study
2026
·
Pingping Liu
, Xue Jing
, et al.
·
Medicine
·
2
Correction: Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials
2026
·
Zhihua Ran
, Yan Chen
, et al.
·
BioDrugs
·
1
PDF
P0775 Efficacy and safety of mirikizumab as maintenance therapy in East Asian patients with moderately to severely active ulcerative colitis: subpopulation results from the phase 3 Lucent-2 study
2026
·
Z Ran
, Y Miao
, et al.
·
Journal of Crohn s and Colitis
Show more works
View as search
Works count:
3
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type